Summary
A bioRxiv preprint reports that mitochondrial DNA mutations arising during mice’s first two months were sufficient to drive age-related pathologies. The authors also found that tissue-specific selection and mitochondrial fusion influenced the mutations’ later fate.
A bioRxiv preprint reports that mitochondrial DNA mutations arising during the first two months of a mouse’s life were sufficient to drive a range of age-related pathologies. The researchers used a new mouse model that let them confine mitochondrial mutagenesis—the generation of mutations—to a defined period. They also report that the fate of these mutations varies across tissues and can be influenced by mitochondrial fusion.
A timed window for mutations
Mitochondria contain their own DNA, separate from the DNA housed in a cell’s nucleus. Mutations in mitochondrial DNA (mtDNA) can therefore arise and behave differently across tissues. The study’s timed model let the researchers examine whether the period when mutations first appear affects later outcomes.
According to the preprint’s abstract, mutations arising in the first two months of life were enough to drive multiple age-related pathologies in the mice. This finding puts the timing of mutations alongside their later fate as a possible factor in age-related decline: the study reports that tissue-specific selective pressures help determine how mtDNA mutations fare as animals age.
Mitochondrial fusion and mutation selection
The researchers also report that they could alter selection against harmful mtDNA variants by manipulating mitochondrial fusion, both in vitro and in vivo. Fusion is the process by which mitochondria join, forming connected structures within cells. The abstract does not specify the direction or size of the reported effects, but it identifies fusion as a factor that can influence how deleterious variants are selected.
The results point to a potential way to study how mitochondrial mutation patterns change over time, and raise the possibility that targeting fusion could affect those patterns. The evidence described is preclinical: it comes from mice and laboratory experiments, not people. The paper is a preprint posted on bioRxiv.